Syensqo SA/NV
SYENS | BR
Overview
Corporate Details
- ISIN(s):
- BE0974464977 (+3 more)
- LEI:
- 549300060XNJ90PLNS10
- Country:
- Belgium
- Address:
- RUE DE LA FUSÉE 98, 1130 BRUSSELS
- Website:
- https://www.syensqo.com
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
At Syensqo, we’re explorers: experts in science and passionate about all its possibilities. Our innovative products and solutions help enhance the way people around the world live life every day: how they work, travel, and spend leisure time. Inspired by the legacy of the Solvay Congresses, which brought together the greatest scientific minds to explore answers to the world’s biggest challenges, we strive to break new ground: addressing the critical needs of today and creating solutions for the future. We’re constantly expanding on what’s seemingly impossible and pushing the limits of what can be realized. With a diverse global team of more than 13,000 employees in 30 countries, we work together to advance science and help humanity move forward.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-24 08:30 |
Declaration of Voting Results & Voting Rights Announcements
20250624_BlackRock_Notification_EN.pdf
|
English | 535.5 KB | |
| 2025-06-24 08:30 |
Declaration of Voting Results & Voting Rights Announcements
20250624_BlackRock_Notification_FR.pdf
|
French | 540.0 KB | |
| 2025-06-24 08:30 |
Declaration of Voting Results & Voting Rights Announcements
20250624_BlackRock_Notification_NL.pdf
|
Dutch | 543.3 KB | |
| 2025-06-09 17:45 |
Transaction in Own Shares
20250609_Acquisition of shares_EN.pdf
|
English | 278.0 KB | |
| 2025-06-09 17:45 |
Transaction in Own Shares
20250609_Acquisition of shares_FR.pdf
|
French | 279.9 KB | |
| 2025-06-09 17:45 |
Transaction in Own Shares
20250609_Acquisition of shares_NL.pdf
|
Dutch | 277.1 KB | |
| 2025-05-09 17:45 |
Transaction in Own Shares
20250509_Shares cancellation_EN.pdf
|
English | 237.6 KB | |
| 2025-05-09 17:45 |
Transaction in Own Shares
20250509_Shares cancellation_FR.pdf
|
French | 238.9 KB | |
| 2025-05-09 17:45 |
Transaction in Own Shares
20250509_Shares cancellation_NL.pdf
|
Dutch | 238.7 KB | |
| 2025-05-06 17:45 |
Declaration of Voting Results & Voting Rights Announcements
20250506_AGM_Outcome_EN.pdf
|
English | 226.0 KB | |
| 2025-05-06 17:45 |
Declaration of Voting Results & Voting Rights Announcements
20250506_AGM_Outcome_FR.pdf
|
French | 230.3 KB | |
| 2025-05-06 17:45 |
Declaration of Voting Results & Voting Rights Announcements
20250506_AGM_Outcome_NL.pdf
|
Dutch | 234.0 KB | |
| 2025-04-04 08:30 |
General Meeting Notice
3. Convocation EN - Final.docx.pdf
|
English | 304.2 KB | |
| 2025-04-04 08:30 |
General Meeting Notice
3. Convocation FR - Final.docx (2).pdf
|
French | 329.5 KB | |
| 2025-04-04 08:30 |
Declaration of Voting Results & Voting Rights Announcements
New -7. Vote par correspondance - NL - Personalised.docx (1).pdf
|
Dutch | 201.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-09 | Roger Davis Christopher | Board | Buy | 875 | 48,795.78 EUR |
| 2025-04-01 | Kadri Ilham | Board | Buy | 11,789 | N/A |
| 2025-03-31 | Roger Davis Christopher | Board | Buy | 9,673 | N/A |
| 2025-03-24 | Tiberghien Hervé | Board | Buy | 7,406 | N/A |
| 2025-03-23 | Chollet Marc | Board | Buy | 5,878 | N/A |
| 2025-03-03 | Tiberghien Hervé | Board | Sell | 3,453 | 236,451.96 EUR |
| 2025-03-03 | Chollet Marc | Board | Sell | 3,420 | 234,192.20 EUR |
| 2025-02-28 | Roger Davis Christopher | Board | Buy | 710 | 49,689.07 EUR |
| 2024-12-23 | Roger Davis Christopher | Board | Buy | 720 | 50,184.00 EUR |
| 2024-11-15 | Meaney Haynes Mary | Board | Buy | 534 | 40,128.17 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
iDNA Genomics Public Ltd | Cyprus | IDNA | |
|
Idorsia Ltd | Switzerland | IDIA | |
|
ILIKA PLC | United Kingdom | IGE | |
|
Indivior PLC | United Kingdom | INDV | |
|
Infant Bacterial Therapeutics | Sweden | IBT | |
|
Initiator Pharma A/S | Denmark | INIT | |
|
Intercure Ltd. | Israel | INCR | |
|
Intervacc AB | Sweden | IVACC | |
|
Ipsen | France | IPN | |
|
J. Molner AS | Estonia | JML |